{
}
Adaptive Biotechnologies Corporation, a biotechnology firm, saw its shares rise 6% following an upgrade from Goldman Sachs. The company focuses on leveraging the adaptive immune system for disease diagnosis and treatment, particularly through its clonoSEQ technology for assessing minimal residual disease in hematologic malignancies.
Goldman Sachs has upgraded Adaptive Biotechnologies to a "Buy" rating from "Neutral," raising the price target to $9 from $8. The company specializes in leveraging the adaptive immune system for disease diagnosis and treatment, focusing on minimal residual disease assessment in lymphoid malignancies and immune-driven drug discovery. Its clonoSEQ technology plays a crucial role in measuring minimal residual disease in hematologic cancers, supporting both clinical diagnostics and biopharmaceutical development.
Teva Pharmaceutical Industries Ltd. (TEVA) has significantly outperformed the Medical sector this year, gaining approximately 67.5% compared to the sector's average of 7.5%. With a Zacks Rank of #2 (Buy) and an improved earnings outlook, Teva stands out in the Medical - Generic Drugs industry, which has seen an average gain of 16.7%. Investors should keep an eye on both Teva and Adaptive Biotechnologies, which has also shown strong performance.
Adaptive Biotechnologies Corporation
Companies
| Symbol | ADPT |
| Name | Adaptive Biotechnologies Corporation |
| Currency | USD |
| Sector | Health Care |
| IndustryGroup | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Market | NASDAQ Global Select |
| Country | United States |
| State | WA |
| City | Seattle |
| Zipcode | 98102 |
| Website | http://www.adaptivebiotech.com |
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
adaptive biotechnologies shares rise after goldman sachs upgrade
20:26 21.03.2025
goldman sachs upgrades adaptive biotechnologies to buy and raises price target
12:18 21.03.2025
teva pharmaceutical industries significantly outperforms medical sector in 2023
09:00 07.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Emerging Startups
Startups & Entrepreneurship
Venture Capital Investments
Funding Rounds & Investments
Fintech Startups
AI Innovations
Retail and Consumer Goods
Economic Indicators
Private Equity Deals
Global Trade Developments
Government Economic Policies
Cryptocurrency Trends
AI Applications
Product Launches
IPOs & SPACs
Macro-economic Trends
Supply Chain Management
Industry Mergers & Acquisitions
Countries:
Companies:
Apple Inc.
Nvidia Corporation
NVIDIA Corporation
Microsoft Corporation
SWIGGY LIMITED
Vecmocon Technologies Ltd.
VOLKSWAGEN AG
Amazon.com Inc.
Medius Holdings Co., Ltd.
SITC International Holdings Company Limited
Firefly AB (publ)
Aeon Bank (M) Berhad Bhd
AF DOBRA, SICAV, S.A.
Alibaba Group Holding Limited
Getty Images Holdings, Inc.
Sunnova Energy International Inc.
QUALCOMM Incorporated
Alphawave IP Group plc
Grab2Go AS
HDB Financial Services Ltd.
Currencies:
People: